Ventas Inc

Ventas Inc

VTR

Get informed when a big investor buys or sells

+ Follow
Market Cap$45.46B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ventas IncVentas Inc322.42.14%1%7.2-

Earnings Call Q2 2026

July 30, 2026 - AI Summary

Strong operating momentum in Senior Housing (SHOP) - Ventas reported 10% total company same-property NOI growth in 2Q26. - U.S. SHOP led with 18% NOI growth and +360 bps occupancy growth YoY, plus occupancy ~87% overall across SHOP (with non-same-store ~83% by design). - Same-store SHOP guidance reaffirmed: ~16% same-store SHOP NOI growth at midpoint for full-year 2026 (driven by the May–Sep “key selling season”; they said results so far are “on track”). - Operating leverage showed up: NOI margins +210 bps YoY to 31% and incremental margin flow-through 55%, implying costs are relatively more fixed as occupancy rises.
Earnings outlook raised; investment activity is the key driver - Normalized FFO per share: $0.97 in 2Q26 (+9% YoY). - Full-year 2026 normalized FFO guidance raised to $3.85–$3.90 per share (~8%–10% YoY growth, midpoint $3.88). - Capital investment guidance raised materially: 2026 investments now expected at $4.5B vs $3.0B previously. - The stronger FFO outlook was attributed to more accretive senior housing investment activity; offset partly by higher interest rates / macro factors, and a share price impact. - Full-year 2026 net income outlook also updated to $0.58–$0.63 per share (midpoint $0.61).
Investment engine accelerating—scale and returns remain central - They reported $3B+ senior housing investments year-to-date across 27 transactions (and $3.4B investments mentioned later; indicates ongoing settlement/close activity within the same timeframe). - Since beginning of 2024, Ventas has completed $8B+ investments, adding 23,000+ units across 174 communities to SHOP. - Underwriting discipline remains: year-to-date deals underwritten to double-digit to mid-teens unlevered IRRs, with ~6.6% average year-1 yield and average price per unit ~$358k, at significant discounts to replacement costs. - Deal process efficiency: underwriting/close described as ~2 months start-to-finish (helpful given competition and time-to-close dynamics).

Exclusive for Stockcircle Pro members

Sign upSign Up
$98.07

Target Price by Analysts

4.9% upsideVentas Target Price DetailsTarget Price
$103.56

Current Fair Value

10.7% upside

Undervalued by 10.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$45.46 Billion
Enterprise Value$45.26 Billion
Dividend Yield$2.00 (2.14%)
Earnings per Share$0.55
Beta0.72
Outstanding Shares482,802,000

Return

Return on Equity0.58%ROE
Return on Assets0.29%
Return on Invested Capital2.69%

Valuation & Multiples

P/E Ratio322.45P/E Ratio
PEG-124.92PEG
Price to Sales7.19Price to Sales
Price to Book Ratio3.02Price to Book Ratio
Enterprise Value to Revenue7.03
Enterprise Value to EBIT56.83
Enterprise Value to Net Income531
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 29, 2026
EPS Estimate
$0.14
Average shareholder expectation
Revenue Estimate
$1.68 B
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.17
Average shareholder expectation
Revenue Estimate
$1.73 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 33.29%
Total Calls100▼ 99.98%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %4.08%▼ 105.19%
Total Invested$1.72B▼ 95.76%
Investors Holding350▼ 595.00%

ESG Score

No data

About Ventas Inc

CEO: Debra Cafaro

Relevant Senate Committees

Finance

Controls federal tax policy (impacting REIT structure and profitability) and critical entitlement spending, particularly Medicare and Medicaid, which are major revenue sources for Ventas's healthcare facility tenants.

Appropriations

Directly controls federal spending, including significant allocations for healthcare programs (Medicare/Medicaid) and medical research, which are critical revenue sources for Ventas's tenants and influence demand for its properties.

Health, Education, Labor, and Pensions

Directly regulates the healthcare sector (FDA, NIH) and labor laws. Decisions on labor costs and healthcare policy significantly affect the operational expenses and profitability of Ventas's healthcare facility tenants.

Banking, Housing, and Urban Affairs

Directly regulates the financial system, including the SEC (which oversees REITs) and real estate markets (HUD). Its decisions on financial regulations and interest rates profoundly impact Ventas's cost of capital, property valuations, and financial viability.